公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2010 | Chronic hepatitis B: Whom to treat and for how long? Propositions, challenges, and future directions | Ahn S.H.; Chan H.L.Y.; PEI-JER CHEN ; Cheng J.; Goenka M.K.; Hou J.; Lim S.G.; Omata M.; Piratvisuth T.; Xie Q.; Yim H.J.; Yuen M.-F. | Hepatology International | 38 | 41 | |
1996 | Chronic hepatitis C without anti-hepatitis C antibodies by second-generation assay: A clinicopathologic study and demonstration of the usefulness of a third-generation assay | JIA-HORNG KAO ; Lai M.-Y.; Hwang Y.-T.; PEI-MING YANG ; PEI-JER CHEN ; JIN-CHUAN SHEU ; Wang T.-H.; Hsu H.-C.; DING-SHINN CHEN | Digestive Diseases and Sciences | 48 | 44 | |
2017 | Chronologic changes in serum hepatitis B virus DNA, genotypes, surface antigen mutants and reverse transcriptase mutants during 25-year nationwide immunization in Taiwan | HONG-YUAN HSU ; MEI-HWEI CHANG ; YEN-HSUAN NI ; Chiang C.-L.; JIA-FENG WU ; HUEY-LING CHEN ; PEI-JER CHEN ; Chen D.-S. | Journal of Viral Hepatitis | 17 | 13 | |
2004 | Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus | PO-REN HSUEH ; LI-MIN HUANG ; PEI-JER CHEN ; CHUAN-LIANG KAO ; PAN-CHYR YANG | Clinical Microbiology and Infection | 197 | 181 | |
2010 | CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells | Chen K.-F.; Liu C.-Y.; Lin Y.-C.; Yu H.-C.; TSUNG-HAO LIU ; Hou D.-R.; PEI-JER CHEN ; ANN-LII CHENG | Oncogene | 148 | 139 | |
2014 | Circulating programmed death-1 as a marker for sustained high hepatitis b viral load and risk of hepatocellular carcinoma e95870 | Cheng H.-Y.; Kang P.-J.; YA-HUI CHUANG ; Wang Y.-H.; Jan M.-C.; Wu C.-F.; Lin C.-L.; CHUN-JEN LIU ; Liaw Y.-F.; Lin S.-M.; PEI-JER CHEN ; Lee S.-D.; MING-WHEI YU | PLoS ONE | 65 | 25 | |
2022 | Circulating Virus–Host Chimera DNAs in the Clinical Monitoring of Virus‐Related Cancers | Li, Chiao Ling; Shiou-Hwei Yeh ; PEI-JER CHEN | Cancers | 3 | 0 | |
2008 | The circulation of subgenogroups B5 and C5 of enterovirus 71 in Taiwan from 2006 to 2007 | Huang Y.-P.; Lin T.-L.; Kuo C.-Y.; Lin M.-W.; Yao C.-Y.; Liao H.-W.; Hsu L.-C.; Yang C.-F.; Yang J.-Y.; PEI-JER CHEN ; Wu H.-S. | Virus Research | 61 | 55 | |
2021 | Clinical and histologic features of patients with biopsy-proven metabolic dysfunction-associated fatty liver disease | SHANG-CHIN HUANG ; Su H.-J; JIA-HORNG KAO ; TAI-CHUNG TSENG ; HUNG-CHIH YANG ; TUNG-HUNG SU ; PEI-JER CHEN ; CHUN-JEN LIU | Gut and Liver | 38 | 32 | |
1997 | Clinical and microbiological features of liver abscess after transarterial embolization for hepatocellular carcinoma | Chen C.; PEI-JER CHEN ; PEI-MING YANG ; GUAN-TARN HUANG ; Lai M.-Y.; Tsang Y.-M.; DING-SHINN CHEN | American Journal of Gastroenterology | 97 | 71 | |
2002 | Clinical and virological aspects of blood donors infected with hepatitis B virus genotypes B and C | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Journal of Clinical Microbiology | 84 | 79 | |
2014 | Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneously | Cheng H.-R.; JIA-HORNG KAO ; Wu H.-L.; Chen T.-C.; TAI-CHUNG TSENG ; CHEN-HUA LIU ; TUNG-HUNG SU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHUN-JEN LIU | Liver International | 13 | 11 | |
2003 | Clinical aspects and outcomes of volunteer blood donors testing positive for hepatitis-C virus infection in Taiwan: A prospective study | CHUN-JEN LIU ; PEI-JER CHEN ; Shau W.-Y.; JIA-HORNG KAO ; Lai M.-Y.; DING-SHINN CHEN | Liver International | 24 | 22 | |
2007 | Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy | WANG-HUEI SHENG ; CHIEN-CHING HUNG ; Wu R.-J.; JANN-TAY WANG ; PEI-JER CHEN ; SHAN-CHWEN CHANG ; JIA-HORNG KAO | Clinical Infectious Diseases | 10 | 8 | |
2014 | Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy | TUNG-HUNG SU ; CHUN-JEN LIU ; HUNG-CHIH YANG ; YUNG-MING JENG ; Cheng H.-R; CHEN-HUA LIU ; TAI-CHUNG TSENG ; THAI-YEN LING ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology | 16 | 14 | |
2015 | Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection | Cheng H.-R.; JIA-HORNG KAO ; Wu H.-L; TAI-CHUNG TSENG ; CHEN-HUA LIU ; HUNG-CHIH YANG ; TUNG-HUNG SU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHUN-JEN LIU | Hepatology International | 14 | 11 | |
2011 | The clinical significance of occult hepatitis B transfusion in Taiwan - a look-back study | TUNG-HUNG SU ; PEI-JER CHEN ; Chen T.-C.; Cheng H.-R.; Li L.; Lin K.-S.; JIA-HORNG KAO ; DING-SHINN CHEN ; CHUN-JEN LIU | Transfusion Medicine | 30 | 26 | |
1996 | Clinical significance of serum hepatitis C virus titers in patients with chronic type C hepatitis | JIA-HORNG KAO ; Lai M.-Y.; PEI-JER CHEN ; Hwang L.-H.; Chen W.; DING-SHINN CHEN | American Journal of Gastroenterology | 31 | 28 | |
1994 | A clinicopathologic study of chronic non-A, non-B (type C) hepatitis in Taiwan: comparison between posttransfusion and sporadic patients | JIA-HORNG KAO ; Tsai S.-L.; PEI-JER CHEN ; PEI-MING YANG ; JIN-CHUAN SHEU ; Lai M.-Y.; Hsu H.-C.; Sung J.-L.; Wang T.-H.; DING-SHINN CHEN | Journal of Hepatology | 38 | 36 | |
2007 | Clinicopathological differences between hepatitis B viral genotype B- and C-related resectable hepatocellular carcinoma | Lin C.-L.; Chen J.-D.; CHUN-JEN LIU ; PO-HUANG LEE ; PEI-JER CHEN ; Lai M.-Y.; JIA-HORNG KAO ; DING-SHINN CHEN | Journal of Viral Hepatitis | 23 | 21 |